<DOC>
	<DOCNO>NCT02790203</DOCNO>
	<brief_summary>Perioperative Celecoxib promote bowel movement reduce post-operative pain elective colonic resection .</brief_summary>
	<brief_title>Perioperative Use Selective COX2 Inhibitor Patients Undergoing Elective Colorectal Surgery : Effect Post-operative Bowel Motility Post-operative Pain</brief_title>
	<detailed_description>Post-operative ileus common surgical complication occur 20 % patient , significant clinical economical effect . Many preventative measure test promote gastrointestinal motility follow intestinal surgery suggest . The medical intervention propose study include administration selective COX-2 inhibitor , specifically Celecoxib , peri-operative period follow elective colon resection . Celecoxib nonsteroidal anti-inflammatory drug ( NSAID ) anti-inflammatory , analgesic , antipyretic therapeutic effect . The drug approve use ministry health Israel United state . The study aim assess use widely use medication evaluation clinical effect post-operative bowel transit , well drug ' effect post-operative pain .</detailed_description>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Patients age 18 80 Patients plan elective colorectal surgery primary anastomosis ASA score 13 Patients able sign inform consent comply protocol Patients inflammatory bowel disease Patients require emergency surgery Patients renal failure , measure Creatinine level &gt; 1.5 mg/dL ( &gt; 106.1 micro mol/l ) Patients significant liver failure ( know cirrhosis , Bilirubin level &gt; 2 mg/dL 34.2 Âµmol/L ) Patients known allergy medication nonsteroidal antiinflammatory drug group . Patients treat chronically type COX inhibitor . Patients treat NSAIDS include Aspirin 7 day prior date surgery . Patients active peptic disease Patient expect take muscle relaxant , tricyclic antidepressant , tranquilizer , sedative , hypnotic neuroleptic postoperative period Patient dysphagia difficulty swallow capsule tablet , unable tolerate oral medication Pregnant / lactate woman . Patients participate interventional clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>